StockNews.AI
EXEL
StockNews.AI
180 days

Exelixis Announces a Newly Authorized $500 Million Stock Repurchase Program

1. Exelixis approves additional $500M stock repurchase before December 2025. 2. Completing an ongoing buyback, the move signals management confidence in valuation.

Shares Buyback
+5.02%Current Return
VS
-1.72%S&P 500
$35.0902/20 05:15 PM EDTEvent Start
$36.8502/21 11:19 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Stock repurchases tend to reduce shares outstanding and boost EPS, historically supporting share price increases. Similar announcements from companies like Apple and Pfizer have led to near-term price rallies.

How important is it?

A $500M+ buyback is substantial, signaling management's confidence and potentially enhancing EPS, which can positively affect the share price.

Why Short Term?

The program's execution beginning in Q2 2025 indicates an imminent market reaction, boosting investor sentiment in the near term.

Related Companies

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that the company's Board of Directors has authorized the repurchase of up to an additional $500 million of the company's common stock before December 31, 2025. Exelixis plans on completing the currently ongoing $500 million stock repurchase program (SRP), announced in August 2024, in the second quarter of 2025, and commence stock repurchases under the newly authorized SRP thereafter. The February 2025 SRP is the fou.

Related News